[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370759-105":59,"doc-detail-370759-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","phf20l1-an-epigenetic-regulator-in-cancer-and-beyond-review","PHF20L1: An Epigenetic Regulator in Cancer and Beyond - Review","","Plant homeodomain (PHD) finger protein 20-like 1 (PHF20L1) is a novel epigenetic “reader” that recognizes histone post-translational modifications (PTMs) via its Tudor and PHD finger domains, thereby regulating chromatin remodelling, DNA damage repair, and oncogene transcriptional activation. The review summarizes PHF20L1’s roles in multiple cancers, including breast, ovarian, colorectal cancers, and retinoblastomas, and explains molecular mechanisms driving tumorigenesis. Evidence links PHF20L1 upregulation to proliferation, metastasis, and immune evasion. The article also proposes strategies for small-molecule inhibitors and combinatorial therapies.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/phf20l1-an-epigenetic-regulator-in-cancer-and-beyond-review/370759/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/phf20l1-an-epigenetic-regulator-in-cancer-and-beyond-review/370759.png","ImageObject",300,407,{"name":92,"@type":93},"Stanley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What biological function does PHF20L1 serve in cancer?","Question",{"text":113,"@type":114},"PHF20L1 functions as an epigenetic reader that recognizes histone PTMs and regulates chromatin remodelling, DNA damage repair, and oncogene transcriptional activation.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which cancers are specifically discussed in the review?",{"text":118,"@type":114},"The review covers multiple malignancies, including breast, ovarian, colorectal cancers, and retinoblastomas.",{"name":120,"@type":111,"acceptedAnswer":121},"How does PHF20L1 influence tumor progression?",{"text":122,"@type":114},"PHF20L1 is upregulated in these cancers and promotes tumor progression by driving proliferation, metastasis, and immune evasion through coordinated gene expression.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},370759,1790469863,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Review  \nPHF20L1: An Epigenetic Regulator in Cancer and Beyond  \nYishan Wang 1, Qin Hu 1,2, Haixia Zhao 1, Lulu Zeng 1, Zhongwei Zhao 1,3,4,5, Xia Li 1,3,4,5, Qiaoyou Weng 1,3,4,5, Yang Yang 1,2,3,4,5, Minjiang Chen 1,2,3,4,5, Jiansong Ji 1,3,4,5,* and Rongfang Qiu 1,3,4,5, *  \nAcademic Editors: Milena Urbini and Jorge Joven  \nReceived: 10 June 2025  \nRevised: 11 July 2025  \nAccepted: 15 July 2025  \nPublished: 18 July 2025  \nCitation: Wang, Y.; Hu, Q.; Zhao, H.; Zeng, L.; Zhao, Z.; Li, X.; Weng, Q.; Yang, Y.; Chen, M.; Ji, J.; et al. PHF20L1: An Epigenetic Regulator in Cancer and Beyond. Biomolecules 2025, 15, 1048. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/biom15071048](10.3390/biom15071048)  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Zhejiang Key Laboratory of Imaging and Interventional Medicine, The Fifth Affliated Hospital of Wenzhou Medical University, Lishui 323000, China; [wangyishan@wmu.edu.cn](wangyishan@wmu.edu.cn) (Y.W.); [huqin@wmu.edu.cn](huqin@wmu.edu.cn) (Q.H.); [zhaohaixia@wmu.edu.cn](zhaohaixia@wmu.edu.cn) (H.Z.); [zenglulu2025@wmu.edu.cn](zenglulu2025@wmu.edu.cn) (L.Z.); [zhongwei-zhao@wmu.edu.cn](zhongwei-zhao@wmu.edu.cn) (Z.Z.); [lixia2025@wmu.edu.cn](lixia2025@wmu.edu.cn) (X.L.); [2111110079@bjmu.edu.cn](2111110079@bjmu.edu.cn) (Q.W.); [yangyang0502@wmu.edu.cn](yangyang0502@wmu.edu.cn) (Y.Y.); [minjiangchen@wmu.edu.cn](minjiangchen@wmu.edu.cn) (M.C.)  \n2 Cixi Biomedical Research Institute, Wenzhou Medical University, Ningbo 315300, China  \n3 Department of Radiology, Lishui Central Hospital, Lishui 323000, China  \n4 Key Laboratory of Precision Medicine of Lishui, Lishui 323000, China  \n5 Clinical College of The Affiliated Central Hospital, School of Medcine, Lishui University, Lishui 323000, China  \n* [Correspondence: jjstcty@wmu.edu.cn](Correspondence: jjstcty@wmu.edu.cn) (J.J.); [qiurongfang2023@wmu.edu.cn](qiurongfang2023@wmu.edu.cn) (R.Q.); Tel.: +86-578-2285011 (J.J. & R.Q.)  \nAbstract  \nPlant homeodomain (PHD) finger protein 20-like 1 (PHF20L1) is a novel epigenetic “reader”that specifically recognises histone post-translational modifications (PTMs) via its Tudor and PHD finger domains, thereby regulating chromatin remodelling, DNA damage repair, and oncogene transcriptional activation. This review comprehensively summarises the role of PHF20L1 in various cancers, including breast, ovarian, and colorectal cancers, as well as retinoblastomas, and elucidates its molecular mechanisms of action in cancer pathogenesis. Accumulating evidence indicates that PHF20L1 is upregulated in these malignancies and drives tumour progression by promoting proliferation, metastasis, and immune evasion. Furthermore, PHF20L1 orchestrates tumour-related gene expression by interacting with key epigenetic complexes. Given its unique structural features, we propose novel strategies for developing small-molecule inhibitors and combinatorial therapies, providing a theoretical basis for targeted epigenetic regulation for precision treatment. Future research should further investigate the molecular regulatory networks of PHF20L1 in different cancers and other human diseases and focus on developing specific small-molecule inhibitors to enable precision-targeted therapies.  \nKeywords: PHF20L1; cancer; epigenetic regulation; histone methylation; targeted therapy  \n1. Introduction  \nEpigenetic dysregulation is a key driver of cancer development, promoting the malignant transformation and adaptive evolution of tumour cells by dynamically regulating chromatin modifications and gene expression programmes [1] . Histone modifications are crucial epigenetic mechanisms. Post-translational modifications (PTMs) of histone prot","cbCail9ChstokIyQ","https://ap.wps.com/l/cbCail9ChstokIyQ","pdf",2143676,"English","# Abstract\n# Introduction\n## Epigenetic dysregulation and histone modifications\n## Writers, erasers, and readers in epigenetic regulation\n## PHF20L1 as an epigenetic reader","[{\"question\":\"What biological function does PHF20L1 serve in cancer?\",\"answer\":\"PHF20L1 functions as an epigenetic reader that recognizes histone PTMs and regulates chromatin remodelling, DNA damage repair, and oncogene transcriptional activation.\"},{\"question\":\"Which cancers are specifically discussed in the review?\",\"answer\":\"The review covers multiple malignancies, including breast, ovarian, colorectal cancers, and retinoblastomas.\"},{\"question\":\"How does PHF20L1 influence tumor progression?\",\"answer\":\"PHF20L1 is upregulated in these cancers and promotes tumor progression by driving proliferation, metastasis, and immune evasion through coordinated gene expression.\"}]","PHF20L1: An Epigenetic Regulator in Cancer and Beyond - Review | PDF",1790190246,48,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/59e12e96aa86dfc146e657aba6119021.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a5d35876639ce9c44e56029febfbd2d6.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/545313d35d68151c29b42b62ba10d925.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4d77650da0c1338d604b22a34fb99d4.webp",980,1385]